Glenn Vallecillos, M.D., F.A.C.S., is a Board Certified Plastic Surgeon in Beverly Hills, California, Principal of DMH Aesthetics Medical Group, and Co-Founder and Chief Scientific Officer of CannaMedica.  He is a Diplomate of the American Board of Plastic Surgery, a Fellow of the American College of Surgeons, an elected Member of the American Society of Plastic Surgeons, and Faculty Member of the California Society of Facial Plastic Surgeons and the Canadian Board of Aesthetic Medicine.
 
Doctor Vallecillos has a practice emphasis in complex facial surgery and revision surgery of the nose and breasts.  He is regarded as a thought leader in the adaptation and utilization of multi-layer soft-tissue remodeling technologies, allowing for the pinnacle in high-definition facial and body contouring.  He pioneered the combination of Vaser-assisted high-definition lipoplasty with Inmode RFAL platforms, creating the ultimate definition available in hyper-esthetic 4D body contouring.  
 
Doctor Vallecillos is an active national and international speaker with participating lectures including Plastic Surgery The Meeting( ASPS), IMCAS-Paris, CSFPS, and ISPAN.  He is a regular contributor to esteemed publications including the European Journal of Plastic Surgery.
 
Doctor Vallecillos has served as a Senior Faculty Member of Palette/Scientiae since 2008, recognized as a leading expert in minimally invasive soft-tissue enhancements, having personally trained thousands of top physicians, surgeons and aesthetic medicine practitioners throughout the United States and abroad on advanced injection techniques. He has sat on the Advisory Boards for Allergan, Suneva, and Hans Biomed. He was the Chief Clinical Investigator for the Coapt Systems Novielle Injectable Filler Study, has worked as a Clinical Investigator for Mentor Corporation, and is a consultant for Inmode and Agnes Medical.
 
His current areas of interest include Stem Cell Translational Medicine and Cellular Reprogramming in its application to Longevity and De-Aging.